341 related articles for article (PubMed ID: 29893227)
21. Psoriatic arthritis: is it time to treat-to-target or target to treat?
Lubrano E; Perrotta FM
Clin Rheumatol; 2017 Dec; 36(12):2633-2635. PubMed ID: 29067586
[TBL] [Abstract][Full Text] [Related]
22. Resistant cases of psoriatic arthritis: how to manage them.
Atzeni F; Sarzi-Puttini P; Vena GA
J Rheumatol Suppl; 2009 Aug; 83():73-5. PubMed ID: 19661549
[TBL] [Abstract][Full Text] [Related]
23. Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis.
Atzeni F; Costa L; Caso F; Scarpa R; Sarzi-Puttini P
J Rheumatol Suppl; 2015 Nov; 93():79-81. PubMed ID: 26523064
[TBL] [Abstract][Full Text] [Related]
24. Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
Lubrano E; Scarpa R
Reumatismo; 2012 Jun; 64(2):107-12. PubMed ID: 22690387
[TBL] [Abstract][Full Text] [Related]
25. TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis.
Lubrano E; Scriffignano S; Perrotta FM
Expert Rev Clin Immunol; 2019 Dec; 15(12):1303-1312. PubMed ID: 31652079
[No Abstract] [Full Text] [Related]
26. Diagnosing and treating psoriatic arthritis: an update.
Boehncke WH; Qureshi A; Merola JF; Thaçi D; Krueger GG; Walsh J; Kim N; Gottlieb AB
Br J Dermatol; 2014 Apr; 170(4):772-86. PubMed ID: 24266754
[TBL] [Abstract][Full Text] [Related]
27. Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
Tucker LJ; Ye W; Coates LC
Curr Rheumatol Rep; 2018 Sep; 20(11):71. PubMed ID: 30229387
[TBL] [Abstract][Full Text] [Related]
28. [[WHAT SHOULD BE KNOWN ABOUT PSORIATIC ARTHRITIS]?].
Kehler T; Čabrijan L
Acta Med Croatica; 2015; 69(2):111-5. PubMed ID: 29076711
[TBL] [Abstract][Full Text] [Related]
29. Oral treatment options for AS and PsA: DMARDs and small-molecule inhibitors.
Chan J; Gladman D
Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):415-426. PubMed ID: 31171312
[TBL] [Abstract][Full Text] [Related]
30. Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors.
Mease PJ
Ann Rheum Dis; 2002 Apr; 61(4):298-304. PubMed ID: 11874829
[TBL] [Abstract][Full Text] [Related]
31. Management of Psoriatic Arthritis: Traditional Disease-Modifying Rheumatic Agents and Targeted Small Molecules.
Soriano ER
Rheum Dis Clin North Am; 2015 Nov; 41(4):711-22. PubMed ID: 26476228
[TBL] [Abstract][Full Text] [Related]
32. Psoriatic arthritis: current therapy and future approaches.
Huynh D; Kavanaugh A
Rheumatology (Oxford); 2015 Jan; 54(1):20-8. PubMed ID: 25125588
[TBL] [Abstract][Full Text] [Related]
33. An overview of biologic disease-modifying antirheumatic drugs in axial spondyloarthritis and psoriatic arthritis.
So A; Inman RD
Best Pract Res Clin Rheumatol; 2018 Jun; 32(3):453-471. PubMed ID: 31171315
[TBL] [Abstract][Full Text] [Related]
34. Emerging drugs for psoriatic arthritis.
Olivieri I; D'Angelo S; Palazzi C; Lubrano E; Leccese P
Expert Opin Emerg Drugs; 2010 Sep; 15(3):399-414. PubMed ID: 20528612
[TBL] [Abstract][Full Text] [Related]
35. Therapies for dactylitis in psoriatic arthritis. A systematic review.
Helliwell PS
J Rheumatol; 2006 Jul; 33(7):1439-41. PubMed ID: 16724369
[TBL] [Abstract][Full Text] [Related]
36. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
[TBL] [Abstract][Full Text] [Related]
37. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA).
Theander E; Husmark T; Alenius GM; Larsson PT; Teleman A; Geijer M; Lindqvist UR
Ann Rheum Dis; 2014 Feb; 73(2):407-13. PubMed ID: 23355078
[TBL] [Abstract][Full Text] [Related]
38. Current treatments and recommendations for Psoriatic Arthritis.
Vivekanantham A; McGagh D; Coates LC
Best Pract Res Clin Rheumatol; 2021 Jun; 35(2):101680. PubMed ID: 33824068
[TBL] [Abstract][Full Text] [Related]
39. Apremilast for the treatment of psoriatic arthritis.
Souto A; Gómez-Reino JJ
Expert Rev Clin Immunol; 2015; 11(12):1281-90. PubMed ID: 26503917
[TBL] [Abstract][Full Text] [Related]
40. [Prognostic factors in psoriatic arthritis].
Fernández Sueiro JL; Lema Gontad JM
Reumatol Clin; 2012 Mar; 8 Suppl 1():S7-9. PubMed ID: 22257679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
